PortfoliosLab logoPortfoliosLab logo
DNA vs. VTI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

DNA vs. VTI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ginkgo Bioworks Holdings, Inc. (DNA) and Vanguard Total Stock Market ETF (VTI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DNA achieves a 17.09% return, which is significantly higher than VTI's 8.80% return.


DNA

1D
9.82%
1M
15.70%
YTD
17.09%
6M
9.20%
1Y
5.88%
3Y*
-47.70%
5Y*
-52.38%
10Y*

VTI

1D
-0.01%
1M
-0.86%
YTD
8.80%
6M
7.33%
1Y
22.77%
3Y*
20.62%
5Y*
11.81%
10Y*
15.14%
*Multi-year figures are annualized to reflect compound growth (CAGR)

DNA vs. VTI - Yearly Performance Comparison


2026 (YTD)20252024202320222021
DNA
Ginkgo Bioworks Holdings, Inc.
17.09%-15.38%-85.47%0.00%-79.66%-21.68%
VTI
Vanguard Total Stock Market ETF
8.80%17.10%23.81%26.05%-19.52%12.28%

Correlation

The correlation between DNA and VTI is 0.46, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.46

Correlation (3Y)
Calculated over the trailing 3-year period

0.48

Correlation (5Y)
Calculated over the trailing 5-year period

0.49

Correlation (All Time)
Calculated using the full available price history since Apr 19, 2021

0.49

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DNA vs. VTI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DNA
DNA Risk / Return Rank: 4848
Overall Rank
DNA Sharpe Ratio Rank: 4545
Sharpe Ratio Rank
DNA Sortino Ratio Rank: 5252
Sortino Ratio Rank
DNA Omega Ratio Rank: 5151
Omega Ratio Rank
DNA Calmar Ratio Rank: 4646
Calmar Ratio Rank
DNA Martin Ratio Rank: 4545
Martin Ratio Rank

VTI
VTI Risk / Return Rank: 6060
Overall Rank
VTI Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
VTI Sortino Ratio Rank: 5757
Sortino Ratio Rank
VTI Omega Ratio Rank: 5858
Omega Ratio Rank
VTI Calmar Ratio Rank: 5858
Calmar Ratio Rank
VTI Martin Ratio Rank: 6969
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DNA vs. VTI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ginkgo Bioworks Holdings, Inc. (DNA) and Vanguard Total Stock Market ETF (VTI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


DNAVTIDifference
Sharpe ratioReturn per unit of total volatility

-1.73

Sortino ratioReturn per unit of downside risk

-1.65

Omega ratioGain probability vs. loss probability

1.10

1.32

-0.22

Calmar ratioReturn relative to maximum drawdown

0.09

2.56

-2.47

Martin ratioReturn relative to average drawdown

0.15

11.37

-11.22

DNA vs. VTI - Sharpe Ratio Comparison

The current DNA Sharpe Ratio is 0.06, which is lower than the VTI Sharpe Ratio of 1.79. The chart below compares the historical Sharpe Ratios of DNA and VTI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

DNA vs. VTI - Drawdown Comparison

The maximum DNA drawdown since its inception was -99.10%, which is greater than VTI's maximum drawdown of -55.45%. Use the drawdown chart below to compare losses from any high point for DNA and VTI.


Loading charts...

Drawdown Indicators


DNAVTIDifference

Max Drawdown

Largest peak-to-trough decline

-99.10%

-55.45%

-43.65%

Max Drawdown (1Y)

Largest decline over 1 year

-66.05%

-8.92%

-57.13%

Max Drawdown (3Y)

Largest decline over 3 years

-94.72%

-19.30%

-75.42%

Max Drawdown (5Y)

Largest decline over 5 years

-99.10%

-25.36%

-73.74%

Max Drawdown (10Y)

Largest decline over 10 years

-35.00%

Current Drawdown

Current decline from peak

-98.37%

-2.86%

-95.51%

Average Drawdown

Average peak-to-trough decline

-79.98%

-8.01%

-71.97%

Ulcer Index

Depth and duration of drawdowns from previous peaks

39.81%

2.01%

+37.80%

Volatility

DNA vs. VTI - Volatility Comparison

Ginkgo Bioworks Holdings, Inc. (DNA) has a higher volatility of 21.26% compared to Vanguard Total Stock Market ETF (VTI) at 4.93%. This indicates that DNA's price experiences larger fluctuations and is considered to be riskier than VTI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


DNAVTIDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.26%

4.93%

+16.33%

Volatility (6M)

Calculated over the trailing 6-month period

71.35%

10.02%

+61.33%

Volatility (1Y)

Calculated over the trailing 1-year period

98.09%

12.80%

+85.29%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

98.06%

17.50%

+80.56%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

96.27%

18.31%

+77.96%

Dividends

DNA vs. VTI - Dividend Comparison

DNA has not paid dividends to shareholders, while VTI's dividend yield for the trailing twelve months is around 1.04%.


PositionTTM20252024202320222021202020192018201720162015
DNA
Ginkgo Bioworks Holdings, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VTI
Vanguard Total Stock Market ETF
1.04%1.12%1.27%1.44%1.66%1.21%1.42%1.78%2.04%1.71%1.92%1.98%

Frequently Asked Questions


DNA and VTI have a correlation of 0.46, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

DNA has higher volatility (21.26%) compared to VTI (4.93%). In terms of maximum drawdown, DNA dropped -99.10% vs VTI's -55.45%.

VTI currently has the higher Sharpe Ratio (1.79 vs 0.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for DNA and VTI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer